Evaluating the evaluation of calendula oil nanoemulsion containing hydrocortisone in dermatitis following radiotherapy in breast cancer: a randomized clinical trial
Phase 2
Recruiting
- Conditions
- dermatitis following radiotherapy in breast cancer.Disorder of the skin and subcutaneous tissue related to radiation, unspecifiedL59.9
- Registration Number
- IRCT20240213061001N1
- Lead Sponsor
- Bojnourd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 51
Inclusion Criteria
Female patients at least 18 years old
Patients with breast cancer who have undergone surgery (or adjuvant treatment) or received neoadjuvant chemotherapy and underwent surgery.
Candidates for breast radiotherapy
Exclusion Criteria
Complete mastectomy
Background or active skin disease
Breast wound that has not been repaired
Allergy to hydrocortisone
Allergy to marigold essential oil
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method